#biotech
$4 Bn Bioburden Testing Markets, 2022-2024 & 2025-2032 - FDA/EMA Requirements, Rising Biosimilars Production and Advances in Rapid Microbial Detection Technologies Drive Adoption
The bioburden testing market presents opportunities driven by stringent regulations and the need for contamination control in pharma, biotech, and medical devices. Growth is expected in consumables and rapid testing instruments. North America leads due to reg…
Citius raises $36.5m for Lymphir commercialisation
The capital includes a $25m term loan and a warrant exercise agreement expected to yield $11.5m.
The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garage
Kiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who built the company from a garage into a global biotech leader, Kiran is ensuring continuity by handing over to a science-d…